1. Evolocumab Is Mainly Prescribed In Fh Patients With/Without Atherosclerotic Cardiovascular Disease (Ascvd) In Lipid/Internal Medicine Units In Spain: A Retrospective, Observational Study (Retoss-Imu). (August 2019) Authors: Masana, L.; López-Miranda, J.; Civeira, F.; Reinares, L.; Maraver, J.M.; Plana, N.; Cuenca, R.; Sanchez, D.; Hernandez, J.L.; Andres, R.; Blanco, A.; Villamayor, S. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗